| BONACA, Marc P., Deepak L. BHATT, Ton Oude OPHUIS, Gabriel STEG, Robert STOREY, Marc COHEN, Julia KUDER, Kyungan IM, Giulia MAGNANI, Andrzej BUDAJ, Pierre THEROUX, Christian HAMM, Jindřich ŠPINAR, Robert G. KISS, Anthony J. DALBY, Felix A. MEDINA, Frederic KONTNY, Philip E. AYLWARD, Eca C. JENSEN, Peter HELD, Eugene BRAUNWALD a marc S. SABATINE. Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial. JAMA Cardiology. Chicago: American Medical Association, 2016, roč. 1, č. 4, s. 425-432. ISSN 2380-6583. Dostupné z: https://dx.doi.org/10.1001/jamacardio.2016.1017. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1359747,
author = {Bonaca, Marc P. and Bhatt, Deepak L. and Ophuis, Ton Oude and Steg, Gabriel and Storey, Robert and Cohen, Marc and Kuder, Julia and Im, Kyungan and Magnani, Giulia and Budaj, Andrzej and Theroux, Pierre and Hamm, Christian and Špinar, Jindřich and Kiss, Robert G. and Dalby, Anthony J. and Medina, Felix A. and Kontny, Frederic and Aylward, Philip E. and Jensen, Eca C. and Held, Peter and Braunwald, Eugene and Sabatine, marc S.},
article_location = {Chicago},
article_number = {4},
doi = {http://dx.doi.org/10.1001/jamacardio.2016.1017},
keywords = {Ticagrelor; DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; CLOPIDOGREL; ASPIRIN},
language = {eng},
issn = {2380-6583},
journal = {JAMA Cardiology},
title = {Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial},
url = {https://jamanetwork.com/journals/jamacardiology/fullarticle/2528235},
volume = {1},
year = {2016}
}
TY - JOUR
ID - 1359747
AU - Bonaca, Marc P. - Bhatt, Deepak L. - Ophuis, Ton Oude - Steg, Gabriel - Storey, Robert - Cohen, Marc - Kuder, Julia - Im, Kyungan - Magnani, Giulia - Budaj, Andrzej - Theroux, Pierre - Hamm, Christian - Špinar, Jindřich - Kiss, Robert G. - Dalby, Anthony J. - Medina, Felix A. - Kontny, Frederic - Aylward, Philip E. - Jensen, Eca C. - Held, Peter - Braunwald, Eugene - Sabatine, marc S.
PY - 2016
TI - Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial
JF - JAMA Cardiology
VL - 1
IS - 4
SP - 425-432
EP - 425-432
PB - American Medical Association
SN - 23806583
KW - Ticagrelor
KW - DUAL ANTIPLATELET THERAPY
KW - MYOCARDIAL-INFARCTION
KW - CLOPIDOGREL
KW - ASPIRIN
UR - https://jamanetwork.com/journals/jamacardiology/fullarticle/2528235
L2 - https://jamanetwork.com/journals/jamacardiology/fullarticle/2528235
N2 - In the PEGASUS-TIMI 54 trial, treatment with ticagrelor reduced the incidence of cardiovascular death,myocardial infarction, or stroke by 15%to 16%among stable patients compared with placebo. However, more patients prematurely discontinued treatment with ticagrelor than with placebo.
ER -
BONACA, Marc P., Deepak L. BHATT, Ton Oude OPHUIS, Gabriel STEG, Robert STOREY, Marc COHEN, Julia KUDER, Kyungan IM, Giulia MAGNANI, Andrzej BUDAJ, Pierre THEROUX, Christian HAMM, Jindřich ŠPINAR, Robert G. KISS, Anthony J. DALBY, Felix A. MEDINA, Frederic KONTNY, Philip E. AYLWARD, Eca C. JENSEN, Peter HELD, Eugene BRAUNWALD a marc S. SABATINE. Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial. \textit{JAMA Cardiology}. Chicago: American Medical Association, 2016, roč.~1, č.~4, s.~425-432. ISSN~2380-6583. Dostupné z: https://dx.doi.org/10.1001/jamacardio.2016.1017.
|
